Header Logo

Connection

James Mulshine to Double-Blind Method

Back to Details
This is a "connection" page, showing publications James Mulshine has written about Double-Blind Method.
James Mulshine
Connection Strength
0.053
Double-Blind Method
  1. Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res. 2004 Mar 01; 10(5):1565-73.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.